Close interactions with infectious disease set both UC Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor of Biomolecular Engineering Rebecca DuBois on the path of studying respiratory syncytial...
Background Understanding the transmission and dispersal of iinfluenza and respiratory syncytial virus (RSV) via aerosolsvia aerosols is essential for the development of preventative measures in hospital environments and...
A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success. A new study from The Ohio State University provides...
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers...
Researchers at Georgia State University say a vaccine containing virus-like microscopic, genetically engineered particles — i.e.: nanoparticles, has been shown to be an effective treatment for respiratory syncytial...